The most common side effects of Mounjaro are digestive issues: nausea, diarrhea, vomiting, constipation, decreased appetite, indigestion, and abdominal pain. In clinical trials, up to 22% of people taking Mounjaro experienced nausea, making it the single most reported side effect. These symptoms are usually temporary, peaking during the first few weeks and fading as your body adjusts.
Digestive Side Effects
Mounjaro slows down how quickly food moves through your stomach and intestines. That’s part of how it helps control blood sugar and reduce appetite, but it also explains why the gut takes the biggest hit when it comes to side effects. In clinical trials, about 1 in 5 people had nausea, 12% to 17% experienced diarrhea, and up to 1 in 10 reported vomiting. Constipation, stomach pain, and indigestion were also reported in more than 5% of participants.
These symptoms tend to cluster around dose increases. Mounjaro is prescribed on a step-up schedule, starting at 2.5 mg and gradually increasing. Each time the dose goes up, digestive side effects can flare again before settling down. One study found that individual episodes were relatively short: diarrhea typically lasted about 3 days, nausea 3 to 4 days, and vomiting 1 to 2 days. Most people find their symptoms resolve once they reach a stable maintenance dose.
Staying hydrated matters more than you might expect. The combination of nausea, vomiting, and diarrhea can lead to dehydration, which the FDA prescribing information specifically flags as a concern. Eating smaller meals, avoiding greasy or heavy foods, and sipping fluids throughout the day are practical steps that many people find helpful, though the official prescribing label doesn’t mandate specific dietary changes. Mounjaro can be taken with or without food, on any day of the week, as long as you keep it consistent.
Decreased Appetite and Weight Changes
Reduced appetite is listed as a common side effect, but for many people using Mounjaro for weight management or type 2 diabetes, it’s also part of the intended effect. The medication activates two gut hormone pathways that signal fullness to the brain. Some people describe it as simply not thinking about food as much, while others find that certain foods, especially rich or fatty ones, become unappealing.
This can occasionally tip into eating too little, which may cause fatigue, lightheadedness, or difficulty getting enough nutrients. Paying attention to balanced meals even when you don’t feel hungry helps prevent this from becoming a problem.
Thyroid Tumor Warning
Mounjaro carries an FDA boxed warning, the most serious type of safety alert, related to thyroid tumors. In animal studies, the drug caused thyroid C-cell tumors in rats at doses comparable to what humans receive, and the risk increased with higher doses and longer treatment. Whether this translates to humans is still unknown.
Because of this uncertainty, Mounjaro is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. Signs to be aware of include a lump or mass in the neck, trouble swallowing, shortness of breath, or persistent hoarseness. Routine screening with blood tests or thyroid ultrasounds hasn’t been shown to reliably catch problems early in people taking this class of medication.
Pancreatitis Risk
Inflammation of the pancreas (pancreatitis) is listed as a serious potential side effect. This is a known concern across the entire class of medications that work on gut hormone receptors, not unique to Mounjaro. Pancreatitis typically causes severe, persistent pain in the upper abdomen that may radiate to your back, often accompanied by nausea and vomiting. The pain is usually distinct from routine stomach discomfort because of its intensity and location. If you experience this kind of pain, it warrants urgent medical attention.
Stomach Paralysis Concerns
Headlines about “stomach paralysis,” or gastroparesis, have raised alarm about this drug class. Gastroparesis involves the stomach losing its ability to empty normally, causing persistent nausea, bloating, and vomiting that doesn’t resolve. In practice, confirmed cases have been rare. As of early 2024, only one case of gastroparesis linked to Mounjaro’s active ingredient had been logged in the FDA’s adverse event reporting system. That’s out of millions of prescriptions written. The far more common experience is temporary slowed digestion that improves over time.
Other Reported Side Effects
Beyond the digestive system, some people notice reactions at the injection site, including redness, itching, or mild pain. These are generally minor and resolve on their own. Serious allergic reactions, including swelling of the face or throat and difficulty breathing, have been reported but are rare. Mounjaro is contraindicated for anyone with a known serious allergy to the drug or its ingredients.
For people with type 2 diabetes who take Mounjaro alongside insulin or other blood sugar-lowering medications, low blood sugar (hypoglycemia) is a risk. Symptoms include shakiness, sweating, confusion, and rapid heartbeat. Mounjaro on its own is less likely to cause hypoglycemia because it stimulates insulin release primarily when blood sugar is elevated, but combining it with certain other diabetes medications changes that equation.
When Side Effects Typically Ease
Most adverse effects show up within the first month, particularly during the dose-escalation phase. Clinical data consistently shows that the frequency and severity of digestive symptoms decrease over time. For the majority of people, symptoms settle within days to a few weeks after each dose adjustment. The pattern is predictable enough that many prescribers will slow down the dose-escalation schedule if side effects are particularly bothersome, giving your body more time to adapt at each level before moving up.
If symptoms persist well beyond the adjustment period or become severe, that’s a signal worth discussing with your prescriber. Options include staying at a lower dose longer, adjusting meal patterns, or in some cases reconsidering whether the medication is the right fit.